Co-administration of simvastatin and cytotoxic drugs is advantageous in myeloma cell lines

Liat Drucker*, Faina Afensiev, Judith Radnay, Hava Shapira, Michael Lishner

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Co-administration of simvastatin and cytotoxic drugs is advantageous in myeloma cell lines'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology